{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T13:11:52Z","timestamp":1783775512140,"version":"3.55.0"},"reference-count":54,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["24BU212"],"award-info":[{"award-number":["24BU212"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Palliat&amp;#65533;Care"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The subcutaneous (SC) route is used routinely in patients with advanced diseases requiring palliative care. Pre-prepared individual doses of medication stored in syringes may facilitate home administration for symptom management; however, there are limited data on the microbiological and physicochemical stability of such formulations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To assess the microbiological and physicochemical stability of the pre-prepared formulations stored in syringes for SC administration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Experimental study of the microbiological and physicochemical stability of pre-filled syringes during storage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Standardised methods of medication preparation were followed for morphine, midazolam, metoclopramide, hyoscine butylbromide, levomepromazine, haloperidol, ondansetron, fentanyl, ketorolac and dexamethasone, as well as drug mixtures (morphine + midazolam and midazolam + levomepromazine). Microbiological stability of morphine, midazolam, metoclopramide, butylbromide and drug mixtures was analysed by culture on conventional media and monitoring growth over 14 days. A total of 200 syringes were analysed. Physicochemical stability was assessed using ultra-high-performance liquid chromatography with ultraviolet detection coupled to a mass spectrometer, pH measurement and visual macroscopic examination, with measurements taken at eight time points, of the formulations stored in capped polypropylene syringes in air-tight bags in the dark at room temperature (22\u00b13\u00b0C) for 12 weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the microbiological stability analysis, all cultures studied were negative. In the physicochemical stability analysis, the formulations studied retained at least 90% of the initial drug concentrations for 12 weeks, except in the case of metoclopramide (for 3 weeks) and showed no significant changes in pH or macroscopic signs of degradation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Formulations aseptically prepared and stored in syringes are microbiologically and physicochemically stable for 12 weeks in the cases of almost all drugs studied, the exception being metoclopramide (which was stable up to week 3). These findings suggest that such formulations show stability characteristics consistent with suitability for SC administration of drugs in palliative home care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/26323524261467431","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T09:44:51Z","timestamp":1783590291000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Medication for subcutaneous administration: Microbiological and physicochemical stability of drug formulations prepared in advance and stored in syringes"],"prefix":"10.1177","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9479-1350","authenticated-orcid":false,"given":"I\u00f1igo","family":"Suberbiola","sequence":"first","affiliation":[{"name":"Osakidetza"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Casado","sequence":"additional","affiliation":[{"name":"Osakidetza"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idoia","family":"de la Caba","sequence":"additional","affiliation":[{"name":"Osakidetza"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Calvo","sequence":"additional","affiliation":[{"name":"Basque Research and Technology Alliance (BRTA)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6141-1469","authenticated-orcid":false,"given":"Lore","family":"Zumeta-Olaskoaga","sequence":"additional","affiliation":[{"name":"Biogipuzkoa Health Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6444-4118","authenticated-orcid":false,"given":"Maddi","family":"Aramburu","sequence":"additional","affiliation":[{"name":"Osakidetza"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"Moreno","sequence":"additional","affiliation":[{"name":"Osakidetza"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(91)90132-H"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2003.06.008"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.12968\/ijpn.2008.14.8.30774"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/1049909113482514"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/0742-969X.2000.11882949"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1478951508000552"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269216310383739"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/104990919901600407"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/104990919401100103"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.12968\/ijpn.2016.22.8.369"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2008.0155"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2007.0176"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269216318773878"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269216312464262"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.22585\/hospdomic.v8i4.222"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/avj.12608"},{"key":"e_1_3_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(99)00181-7"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600770816"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/54.8.913"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2018-001553"},{"key":"e_1_3_7_22_2","first-page":"78","article-title":"Long-term stability of morphine hydrochloride in 0.9% NaCl infusion polyolefin bags after freeze-thaw treatment and in polypropylene syringes at 5 degrees C + 3 degrees C","volume":"18","author":"Hecq J-D","year":"2014","unstructured":"Hecq J-D, Godet M, Gillet P, et al. Long-term stability of morphine hydrochloride in 0.9% NaCl infusion polyolefin bags after freeze-thaw treatment and in polypropylene syringes at 5 degrees C + 3 degrees C. Int J Pharm Compd 2014; 18: 78\u201382.","journal-title":"Int J Pharm Compd"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.4212\/cjhp.v66i3.1253"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/53.13.1583"},{"key":"e_1_3_7_25_2","first-page":"107","article-title":"Compatibility of haloperidol and hyoscine-N-butyl bromide in mixtures for subcutaneous infusion to cancer patients in palliative care","volume":"11","author":"Barcia E","year":"2003","unstructured":"Barcia E, Reyes R, Luz AM, et al. Compatibility of haloperidol and hyoscine-N-butyl bromide in mixtures for subcutaneous infusion to cancer patients in palliative care. Support Care Cancer 2003; 11: 107\u2013113. https:\/\/doi.org\/10.1007\/s00520-002-0415-7","journal-title":"Support Care Cancer"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.1994.tb00695.x"},{"key":"e_1_3_7_27_2","first-page":"66","article-title":"Physical and chemical stability of low and high concentrations of morphine sulfate with clonidine hydrochloride packaged in plastic syringes","volume":"6","author":"Xu QA","year":"2002","unstructured":"Xu QA, Trissel LA, Pham L. Physical and chemical stability of low and high concentrations of morphine sulfate with clonidine hydrochloride packaged in plastic syringes. Int J Pharm Compd 2002; 6: 66\u201369.","journal-title":"Int J Pharm Compd"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2710.1998.00141.x"},{"key":"e_1_3_7_29_2","unstructured":"Demor\u00e9 B Raffy F Commun N. Etude de la stabilit\u00e9 de deux benzamides anti\u00e9m\u00e9tiques en poches PVC de chlorure de sodium 0.9% et de glucose 5% sur une p\u00e9riode de 5 mois. J Pharm Clin; 14: 178\u2013179."},{"key":"e_1_3_7_30_2","first-page":"04","article-title":"Stability-Indicating HPLC Assay and Stability Study Over Two Years of Morphine Hydrochloride Diluted Solutions in Polypropylene Syringes","author":"d\u2019Hayer B","unstructured":"d\u2019Hayer B, Vieillard V, Astier A, et al. Stability-Indicating HPLC Assay and Stability Study Over Two Years of Morphine Hydrochloride Diluted Solutions in Polypropylene Syringes. Pharm Anal Acta: 04. https:\/\/doi.org\/10.4172\/2153-2435.1000205, Epub ahead of print 2013.","journal-title":"Pharm Anal Acta"},{"key":"e_1_3_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eimc.2022.07.001"},{"key":"e_1_3_7_32_2","volume-title":"Real Farmacopea Espa\u00f1ola","author":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS)","year":"2015","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS) (ed). Real Farmacopea Espa\u00f1ola. 5th ed. AEMPS, 2015.","edition":"5"},{"key":"e_1_3_7_33_2","volume-title":"European Pharmacopoeia","author":"European Directorate for the Quality of Medicines & HealthCare","year":"2023","unstructured":"European Directorate for the Quality of Medicines & HealthCare. European Pharmacopoeia. 13th ed. Council of Europe, 2023.","edition":"13"},{"key":"e_1_3_7_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.12001"},{"key":"e_1_3_7_35_2","article-title":"GRANMO. Calculadora de tama\u00f1o muestral","author":"Instituto Municipal de Investigaci\u00f3n M\u00e9dica","unstructured":"Instituto Municipal de Investigaci\u00f3n M\u00e9dica. GRANMO. Calculadora de tama\u00f1o muestral. GRANMO. https:\/\/www.datarus.eu\/aplicacion\/granmo\/ (accessed 1 May 2026).","journal-title":"GRANMO"},{"key":"e_1_3_7_36_2","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp070681"},{"key":"e_1_3_7_37_2","unstructured":"R Foundation for Statistical Computing. R: A language and environment for statistical computing 2024. https:\/\/www.r-project.org\/ (accessed 1 May 2026)."},{"key":"e_1_3_7_38_2","first-page":"2040","article-title":"Stability of morphine sulfate in Cormed III (Kalex) intravenous bags","volume":"47","author":"Altman L","year":"1990","unstructured":"Altman L, Hopkins RJ, Ahmed S, et al. Stability of morphine sulfate in Cormed III (Kalex) intravenous bags. Am J Hosp Pharm 1990; 47: 2040\u20132042.","journal-title":"Am J Hosp Pharm"},{"key":"e_1_3_7_39_2","first-page":"71","article-title":"Subcutaneous drug administration in palliative care","volume":"39","author":"Matoses Chirivella C","year":"2015","unstructured":"Matoses Chirivella C, Rodr\u00edguez Lucena FJ, Sanz Tamargo G, et al. Subcutaneous drug administration in palliative care. Farm Hosp 2015; 39: 71\u201379. https:\/\/doi.org\/10.7399\/fh.2015.39.2.7544","journal-title":"Farm Hosp"},{"key":"e_1_3_7_40_2","first-page":"72","article-title":"Chemical stability of metoclopramide hydrochloride injection diluted with 0.9% sodium chloride injection in polypropylene syringes at room temperature","volume":"9","author":"Gupta VC","year":"2005","unstructured":"Gupta VC. Chemical stability of metoclopramide hydrochloride injection diluted with 0.9% sodium chloride injection in polypropylene syringes at room temperature. Int J Pharm Compd 2005; 9: 72\u201374.","journal-title":"Int J Pharm Compd"},{"key":"e_1_3_7_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/53.11.1300"},{"key":"e_1_3_7_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2004.02.002"},{"key":"e_1_3_7_43_2","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2007.0028"},{"key":"e_1_3_7_44_2","unstructured":"Barcelona: Bayer Hispania SL 2022. VV. AA. Monograf\u00edas de Farmacia Hospitalaria: Centralizaci\u00f3n de la elaboraci\u00f3n de medicamentos en los servicios de farmacia hospitalaria (n\u00b0 18). Chapter 4: Aspectos b\u00e1sicos en el desarrollo de estudios de estabilidad de medicamentos y su aplicacion en los servicios de farmacia. ISBN: 978-84-09-45458-7."},{"key":"e_1_3_7_45_2","doi-asserted-by":"publisher","DOI":"10.1177\/0310057X0803600508"},{"key":"e_1_3_7_46_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9030107"},{"key":"e_1_3_7_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198502000-00015"},{"key":"e_1_3_7_48_2","doi-asserted-by":"publisher","DOI":"10.1163\/1568569053421762"},{"key":"e_1_3_7_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.patbio.2004.09.007"},{"key":"e_1_3_7_50_2","doi-asserted-by":"publisher","DOI":"10.5731\/pdajpst.2025-000002.1"},{"key":"e_1_3_7_51_2","first-page":"35","article-title":"Stability of morphine hydrochloride solutions in portable single-use PCA systems. Additives leaching into the morphine solutions","volume":"17","author":"Le Hoang MD","year":"1998","unstructured":"Le Hoang MD, Sarbach C, Prognon P. Stability of morphine hydrochloride solutions in portable single-use PCA systems. Additives leaching into the morphine solutions. Journal de Pharmacie Clinique 1998; 17: 35\u201339.","journal-title":"Journal de Pharmacie Clinique"},{"key":"e_1_3_7_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(96)04813-2"},{"key":"e_1_3_7_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxaa040"},{"key":"e_1_3_7_54_2","doi-asserted-by":"publisher","DOI":"10.1515\/pthp-2017-0013"},{"key":"e_1_3_7_55_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002809402800604"}],"container-title":["Palliative Care and Social Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/26323524261467431","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/26323524261467431","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/26323524261467431","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:17:48Z","timestamp":1783772268000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/26323524261467431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":54,"alternative-id":["10.1177\/26323524261467431"],"URL":"https:\/\/doi.org\/10.1177\/26323524261467431","relation":{},"ISSN":["2632-3524","2632-3524"],"issn-type":[{"value":"2632-3524","type":"print"},{"value":"2632-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"article-number":"26323524261467431"}}